Sonoma pharmaceuticals reports q3 shr loss $0.72

Sonoma pharmaceuticals reports third quarter fy 2020 financial results.q3 revenue fell 11 percent to $4.678 million."expect that our revenues and earnings will fluctuate in near-term".qtrly loss per share of $0.72.

SNOA Ratings Summary

SNOA Quant Ranking